(The Woodlands, TX) entered into a research agreement with The Methodist Hospital Research Institute to search for biomarkers and develop a suite of tests that directly impact the diagnosis of
neurodegenerative diseases.
"The function of this particular protein in
neurodegenerative diseases is not yet clear, however, the presence of signaling domains implies that other proteins may participate in the pathway.
Cerveau's vision is to globally develop diagnostics and technology that positively impact patients with
neurodegenerative disorders including Alzheimer's disease and is currently focused on the development of the MK-6240 Tau Imaging biomarker.
This biochemical data was used to compare blood samples from cases of Alzheimer's disease and other
neurodegenerative diseases with those from healthy controls.
When present in appropriate concentrations, these factors also protect nerve cells against damage in stroke, trauma, and many
neurodegenerative disorders including Alzheimer's and Parkinson's diseases.
Alzheimers disease is a chronic, progressive,
neurodegenerative disease characterized by formation of protein deposits known as plaques (made of amyloid-beta protein) and neurofibrillary tangles (made of tau protein) in patients brains.
Voyager Therapeutics (VYGR) and AbbVie (ABBV) announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other
neurodegenerative diseases.
Takeda Pharmaceutical Company Ltd (TSE: 4502) and Denali Therapeutics (NASDAQ: DNLI) have entered into a strategic option and collaboration agreement for
neurodegenerative diseases, the two firms announced on Friday.
2, said the team has found the novel role of Galectin-3 (Gal3) in promoting microglia-mediated neuroinflammation -- which subsequently worsens
neurodegenerative disorders like Huntington's disease and Alzheimer's.
ENPNewswire-August 13, 2019--AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in
Neurodegenerative Diseases
CCM enables real-time imaging of the corneal nerve fibers and identifies nerve damage in a growing list of peripheral and central
neurodegenerative conditions.
Neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, corticobasal degeneration, multiple system atrophy and progressive supranuclear palsy.
